Recombinant TFPI (Concizumab Biosimilar) antibody
The Humanized Chimeric anti-TFPI (Concizumab Biosimilar) antibody is suitable to detect TFPI (Concizumab Biosimilar) in samples from Human.
Catalog No. ABIN7597600
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant TFPI (Concizumab Biosimilar) antibody (ABIN7597600)
Target
TFPI (Concizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This TFPI (Concizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Concizumab Biosimilar Antibody
-
Specificity
- Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor, TFPI, EPI, LACI, TFPI1, Tissue factor pathway inhibitor
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.73 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TFPI (Concizumab Biosimilar)
-
Alternative Name
- Concizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor, TFPI, EPI, LACI, TFPI1, Tissue factor pathway inhibitor
-
UniProt
- P10646
-
CAS-No
- 1312299-39-0
Target
-
You are here:
